Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types. The possibilities arising from stem cell characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, toxicology screening, and more.
To facilitate research resulting from interest in these potential far-ranging applications, a large and growing stem cells research products market has emerged. One of the important segments within the stem cell research products market is primary cells products.
In news released today, Creative Bioarray of Shirley, New York, announced that it has expanded its product portfolio by adding new primary cells products that include human hepatic (liver) cells and mouse primary cells.
To learn more about the announcement, view the full press release from Creative Bioarray below.
Creative Bioarray Launches Primary Cells to Speed Biological Discoveries
5 Feb, 2016 – Creative Bioarray, a US-based biotechnology company focused on research products and tools, today announced that it has expanded its product portfolio by adding a number of new primary cells products such as human hepatic cells and mouse primary cells. Researchers can now more efficiently study predictive cell models and human disease with the launch of various primary cell types.
Primary cells are isolated from an animal or human tissue; they are ideal models for cancer biomarker discovery, drug screening, cancer development, cancer stem cells. The newly released primary cells like the human gastrointestinal cells and human nervous cells can provide researchers with more meaningful answers to their research questions.
“At Creative Bioarray, we provide human& animal primary cells to clients for research purposes,” says Dennis A. Walker, Ph.D., the senior scientific officer at Creative Bioarray. “We are very excited to see how the application of primary cells will enable biological scientists to produce better experimental results for scientific development.”
“This new release for academic and pharma/biotech sectors in North America and Europe will provide researchers with an understanding of the product features that drive customer satisfaction with primary cell products,” adds Hannah Cole, Ph.D., senior scientific officer of R&D department of Creative Bioarray.
About Creative Bioarray:
Found in 2004, Creative Bioarray is an innovative biotechnology company whose mission is to develop unique technologies that provide researchers with the tools to investigate life science.
Creative Bioarray provides a wide range of high quality normal human and animal cells, cell culture medium and reagents, FISH probes, tissue array, microorganisms, equipments and related services for the research community. Their products are currently used around the world in the biological laboratories of universities, government institutes, biotechnology and pharmaceutical companies in more than 50 countries and districts.
Want to be better informed than your competition? Get future stem cell industry updates.
BioInformant is the only research firm to serve the stem cell sector since it emerged. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.